Home > News > pSivida's biosilicon does its job, then goes away
May 27th, 2005
pSivida's biosilicon does its job, then goes away
Abstract:
Howard Lovy: Every one of pSivida's first "customers," are going to die. And they're going to die of the disease that the Australian nanobio company's product is designed to treat. But if BrachySil, the company's lead product, gives liver cancer patients the gift of another year of life without the pain of chemotherapy, then that would count as pSivida's first success.
Source:
Howard Lovy's NanoBot
Bookmark:
| Related News Press |
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||